MANGIACAPRA, FABIO
 Distribuzione geografica
Continente #
AS - Asia 4.965
NA - Nord America 1.908
EU - Europa 695
SA - Sud America 157
Continente sconosciuto - Info sul continente non disponibili 54
OC - Oceania 44
AF - Africa 22
Totale 7.845
Nazione #
SG - Singapore 4.093
US - Stati Uniti d'America 1.834
CN - Cina 430
IT - Italia 311
HK - Hong Kong 152
BR - Brasile 108
VN - Vietnam 81
GB - Regno Unito 74
DE - Germania 68
BD - Bangladesh 58
FR - Francia 58
IN - India 44
AU - Australia 43
NL - Olanda 43
CZ - Repubblica Ceca 40
CA - Canada 33
AR - Argentina 20
MX - Messico 16
ID - Indonesia 15
PH - Filippine 13
FI - Finlandia 12
RU - Federazione Russa 12
EC - Ecuador 11
IR - Iran 9
JP - Giappone 9
PK - Pakistan 9
PL - Polonia 9
TR - Turchia 9
ZA - Sudafrica 9
CO - Colombia 8
BE - Belgio 7
JM - Giamaica 6
MY - Malesia 6
CR - Costa Rica 5
ES - Italia 5
IQ - Iraq 5
LT - Lituania 5
MD - Moldavia 5
RO - Romania 5
UA - Ucraina 5
DO - Repubblica Dominicana 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AT - Austria 3
CL - Cile 3
IL - Israele 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
SE - Svezia 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MA - Marocco 2
PE - Perù 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MK - Macedonia 1
MQ - Martinica 1
NI - Nicaragua 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
SL - Sierra Leone 1
Totale 7.788
Città #
Ashburn 596
San Jose 308
Singapore 296
Rome 172
Hong Kong 149
Dallas 135
Beijing 109
Hefei 102
Council Bluffs 74
Boardman 65
Phoenix 54
Columbus 52
London 46
Lauterbourg 45
Los Angeles 31
Munich 31
Amsterdam 30
New York 28
Brno 27
Shanghai 26
Santa Clara 25
Ho Chi Minh City 24
Perth 22
Hanoi 18
San Francisco 16
West Jordan 16
Milan 12
Seattle 12
Olomouc 10
Mexico City 9
Orem 9
Bengaluru 8
Montreal 8
Palermo 8
Shenzhen 8
Washington 8
Frankfurt am Main 7
Johannesburg 7
Las Vegas 7
Manchester 7
Melbourne 7
São Paulo 7
Atlanta 6
Bocholt 6
Bologna 6
Brooklyn 6
Helsinki 6
North Bergen 6
Tokyo 6
Warsaw 6
Chennai 5
Chicago 5
Da Nang 5
Karachi 5
Kingston 5
Miami 5
Naples 5
Nuremberg 5
Pune 5
Quezon City 5
Surat 5
Turku 5
Xi'an 5
Buffalo 4
Guayaquil 4
Hanover 4
Philadelphia 4
Porto Alegre 4
Quận Ninh Kiều 4
San José 4
Shijiazhuang 4
Toronto 4
Târgu Mureş 4
Zhengzhou 4
Zhoukou 4
Aubin Grove 3
Bandung 3
Bogotá 3
Boston 3
Brasília 3
Brisbane 3
Campinas 3
Conroe 3
Durham 3
Florence 3
George Town 3
Guangzhou 3
Haiphong 3
Harrisburg 3
Newark 3
Portland 3
Quilmes 3
Quito 3
Rio de Janeiro 3
Santo Domingo 3
St Louis 3
Staten Island 3
Stuttgart 3
Sydney 3
Taipei 3
Totale 2.867
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 464
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 286
Current management and prognosis of patients with recurrent myocardial infarction 264
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 253
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 248
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 246
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 246
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 233
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 233
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 226
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 224
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 218
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. 216
Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure 215
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients) 215
Gender-Based Specificities of Fractional Flow Reserve Measurement 211
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 200
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 189
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 173
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 156
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 156
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 153
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 144
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 139
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention 139
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 137
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 136
Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention 134
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 131
High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality 128
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 123
Invasive Assessment of Coronary Microvascular Function 120
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 119
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 117
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 111
CARDIAC ANTHRACYCLINE ACCUMULATION AND B-TYPE NATRIURETIC PEPTIDE TO DEFINE RISK AND PREDICTORS OF CANCER TREATMENT RELATED EARLY DIASTOLIC DYSFUNCTION 108
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 106
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis 92
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 88
Synergistic effect of myocardial injury and mid-regional proAdrenomedullin elevation in determining clinical outcomes of SARS-CoV-2 patients 78
Impact of Tourniquet Use on Systemic Inflammatory Parameters, Functional Physical Recovery, and Cardiovascular Outcomes of Patients Undergoing Knee Arthroplasty: A Case-Control Study 76
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 75
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 69
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 67
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 67
Natural History of Coronary Atherosclerosis in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: The Role of Quantitative Flow Ratio 66
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 56
Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention 53
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 50
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 50
Idiopathic sensorineural hearing loss is associated with endothelial dysfunction 41
Totale 7.845
Categoria #
all - tutte 28.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202253 0 0 0 3 0 0 0 0 0 0 7 43
2022/202369 2 2 5 9 12 0 0 3 2 0 34 0
2023/2024555 3 18 17 26 14 71 33 265 31 28 10 39
2024/20254.343 54 17 72 30 25 67 58 35 113 259 1.695 1.918
2025/20262.227 185 170 160 209 114 131 524 138 165 233 120 78
2026/2027596 21 199 183 193 0 0 0 0 0 0 0 0
Totale 7.845